We believe that true partnerships are created from people who make each other stronger. The real test of a partnership is whether it can endure the bad times; anybody can be your partner during good times.
The construction of our management team reflects these beliefs. In our view, success in private equity investing requires the active participation of individuals with experience in large
and small operating companies, academia and government, as well as private equity. To that end, Ampersand has built a team which integrates three sets of critical skills:
|
|
- In-depth knowledge of the relevant technologies and markets; |
|
|
|
- Senior general management experience in applicable industries; |
|
|
|
- Expertise in financial structuring, small company development and liquidity generation. |
|
|
|
Ampersand’s management team is led by eight Partners. The team members include:
General Partner
Stuart joined Ampersand in 1991, following three years of consulting experience at Bain and five years in manufacturing and engineering at Lever Brothers. Serving as the full-time CFO of ADFlex Solutions during the design and implementation of its turnaround, he has been a director of more than 10 companies including ADFlex, Northfield and Tomah. He currently sits on the board of Assay Designs, Magellan and Talecris. He holds a B.S. in Chemical Engineering from Columbia and an M.B.A. from Harvard Business School.
Managing General Partner
Rick has more than twenty-five years of private equity experience. He joined Ampersand's predecessor in 1980 and led its activities beginning in 1983. The Managing General Partner of all of Ampersand's partnerships, he founded the firm in 1988 and structured its spinoff from PaineWebber. Rick has served as a director of more than thirty-five companies and as Chairman of more than ten. Rick holds an M.S. in Physics and a Ph.D. in Economics and Finance, both from MIT.
Principal
Jared joined Ampersand in 2007 as Principal. Previously, Jared was a Senior Associate at Wellspring Capital Management, where he worked on a number of leveraged acquisitions and recapitalizations of middle-market companies. Prior to joining Wellspring, Jared was with JPMorgan Chase & Co. in the Financial Sponsor Group focusing on acquisition finance and exit alternatives for private equity clients. Jared holds a B.A. in Economics and Computer Science from Middlebury College.
Associate, DTE Team
Thomas joined Ampersand in 2005 to support our Direct to Entrepreneur (DTE) lead sourcing program. Prior to Ampersand he was at Aleutian Capital Partners (ACP) where he was active in the Company’s deal sourcing and deal diligence efforts. Thomas holds a M.B.A. from Pace University and B.A. in Economics from the University of Pretoria in South Africa.
General Partner
Marc joined Ampersand in 2002 from Moldflow Corporation (Nasdaq: MFLO), an Ampersand portfolio company, where he was Chairman, President and CEO. Marc brings more than fourteen years experience as a senior information technology executive, including serving as Senior VP of Marketing at Parametric Technology and in various positions at Nortel. Marc serves as Chairman of FirstRain and RAND and on the boards of Kortec and RadPharm. He holds an M.Eng. in Mechanical Engineering from Carleton University.
Associate, DTE Team
Eric joined Ampersand in 2007 to support our Direct to Entrepreneur (DTE) lead sourcing program. Prior to Ampersand he was at Landmark Partners where he was active monitoring the firm’s fund-of-funds portfolios and with deal diligence efforts. He also worked previously at Salomon Smith Barney. Eric holds a B.A. in Economics from Trinity College in Connecticut.
Senior Accountant
Julie joined Ampersand’s accounting and finance team in 2003. Prior to Ampersand she held accounting positions at PHT Corporation and at Enermetrix. Julie holds a B.S. in Business Administration with a concentration in Accounting from Lasell College and a M.B.A. from Bentley College.
General Partner
Peter joined Ampersand as General Partner in 2008. Prior to Ampersand Peter served as President and CEO of Cohesive Technologies, a bioanalytical equipment company that was sold to Thermo-Fisher; and as President of Primedica, a pharmaceutical services business that was acquired by Charles River Labs. Previously, Peter served as VP of Corporate Development at TSI Corporation, and as a management consultant at Bain & Company. Peter is Chairman and a founder of Agilux Laboratories and a Director of IBT Laboratories. He holds an M.S. in Management from MIT and a B.S. in Economics from Wharton.
Managing General Partner
Herb has over fifteen years of experience working with Healthcare Technology companies, first as an entrepreneur at Ampersand portfolio company ACLARA Biosciences, and later as an Ampersand General Partner. Herb became a Managing General Partner of Ampersand in early 2008. He currently serves as Chairman at ChanTest, Magellan and RadPharm and as a director of Assay Designs, Cequent, IBT Labs, Signature Genomic Labs and Victory Pharma. He previously served as a director of ACLARA, CRI, Cyclis, Medifacts and Panacos. Herb holds a B.S. in Chemical Engineering from North Carolina State University and a Ph.D. in Chemical Engineering from the University of California, Berkeley.
General Counsel
David joined Ampersand in 2005. From 2001 to 2005 he was Vice President and General Counsel of ArQule (Nasdaq: ARQL), where he participated in the acquisition of Cyclis. Previously, he served as Senior Counsel in the Biomedical Services division of the American Red Cross in Washington, DC. Prior to joining the Red Cross, David practiced in the fields of tax and international transactions at the law firms of Kramer, Levin, Nessen & Frankel in New York City and Shimron, Molcho & Persky in Jerusalem. David holds a B.A. from Columbia College, an M.A. from the Jewish Theological Seminary and a J.D. from Columbia Law School.
Partner
Sue joined Ampersand in 2005 from Moldflow Corporation, a former Ampersand portfolio company, where she served as Executive VP of Finance and Administration and as CFO for eight years. Sue brings over twenty-five years of experience in the technology industry including as CFO of Scitex America Corporation and Autographix. She currently serves on the boards of RAND and Sierra Concrete Design. Sue holds a B.A. in Business from Stonehill College and is a C.P.A.
Director of Operations
Caroline joined Ampersand in 1998 to coordinate its deal flow, fundraising and administrative operations. Prior to Ampersand she was the Assistant Director of the Innovations in American Government Program at Harvard's Kennedy School of Government. Caroline holds a B.A. from Trinity College.
Venture Partner
Larry joined Ampersand in 2007 as a Venture Partner and currently serves as Executive Chairman of IBT Laboratories, Director of Magellan Biosciences and as an Observer at Signature Genomic Labs. As the Chairman and Chief Technology of Focus Diagnostics, he built Focus from a $2 million business to a leading esoteric lab with over $80 million in revenues by the time of its acquisition by Quest Diagnostics in 2006. Prior to Focus, Larry served in various positions at Boehringer Mannheim and Becton Dickinson. He holds a PhD in Microbiology from the University of New Hampshire, and served on the faculty of Johns Hopkins and at the University of North Carolina.
Controller
Loretta joined Ampersand in 1998 with responsibility for all tax and general ledger records. Prior to Ampersand she was the Senior Tax Manager with Feeley & Driscoll. Loretta holds a B.A. from Regis College, an M.B.A. from Suffolk University, an M.S.T. from Bentley College, a J.D. from Suffolk University and a C.P.A. Certificate.
Venture Partner
David joined Victory Pharma as EVP and CFO in late 2007 following 13 years as a Partner of Ampersand Ventures. David is also Chairman of Ortho Organizers and a director of Signature Genomic Labs. His past experience includes as CFO at Ampersand portfolio companies ACLARA and NOVEX and board seats at Assay Designs, LTI Lighting, IBT Laboratories and Stereotaxis. Prior to Ampersand, David spent five years consulting at Bain and Mercer and four years in corporate lending at Bank of Boston.
Partner
Todd joined Ampersand in 2005 to spearhead Ampersand’s Direct-to-Entrepreneur (DTE) lead sourcing program by identifying and evaluating new investment opportunities. Previously, Todd was a Senior Associate at Summit Partners, a late-stage private equity firm, and a Financial Analyst in the investment banking division of Advest Inc. He currently serves on the board of K-TEK and as a board observer at ChanTest. Todd holds a B.A. in Economics from Bates College and an M.B.A. from Harvard Business School.
Venture Partner
Doug joined Ampersand as a Venture Partner in 2007. Most recently he was a Managing Director at JMH Capital where, for four years, he focused on making equity investments in lower middle market buyouts. Doug has expertise in value-added distribution, niche manufacturing, and other industrial process businesses. Prior to JMH, he spent over ten years at Monitor Group as the CEO of Monitor Equity Advisors advising private equity and venture investors in a variety of industries. In addition to an M.B.A. from Harvard and a J.D. from Yale, he holds undergraduate degrees in Electrical Engineering and Political Science from MIT.
Director of Finance
Cindy joined Ampersand in 2001 to manage its financial operations. Prior to Ampersand she was a Vice President at Silicon Valley Bank in the Private Banking Division and an Investor Relations Manager at IDX Systems Corp. Cindy holds an A.B. in Economics from Wheaton College and an M.B.A. from Bentley College.
Venture Partner
Tim rejoined Ampersand as Venture Partner in 2007. Prior to this he was Chairman, President and CEO of John H. Harland Co, a $1B NYSE company, before selling it to MacAndrews and Forbes. A General Partner of Ampersand from 1990 to 1993, Tim played a major role in establishing Ampersand’s position in corporate spinoffs. Tim has also served as President of Alcan Aluminum’s U.S. subsidiary and CEO of Boral Industries. He holds a B.S. in Economics from Dalhousie University, an M.S. in Marketing from the University of Lancaster and attended Harvard’s Advanced Management Program.
General Partner
Charlie, who has 20 years of private equity experience, joined Ampersand’s predecessor in 1985. He has served on the boards of numerous companies, including serving as Chairman of Kroy Building Products, Moldflow and Silicon Wave. Charlie is currently Chairman of Kortec, K-TEK and Sierra Concrete Design and a director of Ortho Organizers. Formerly a systems engineer and manufacturing specialist at Hewlett-Packard, Charlieholds a B.S. in Electrical Engineering and an M.S. in Management, both from MIT.
|
